The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...

Healthcare professionals should consider asking people about gambling when speaking to them about smoking and alcohol consumption during a health check or GP appointment, new guidance recommends.

New and innovative mechanisms of action are constantly being discovered and developed into medicines that tackle a broad ...

NICE has been collaborating with NHS England on the Chemotherapy Dose Standardisation initiative which has been developed by the Medicines Optimisation and Chemotherapy Clinical Reference Groups (CRGs ...

NICE, in collaboration with other international health technology assessment agencies, has published a new report which offers guidance on best practice for using surrogate endpoints in health ...

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee B. Committee members are asked to declare any interests in the vadadustat being ...

NICE is unable to make a recommendation about the use in the NHS of niraparib (Zejula) with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This ...